Announcements Trials
Browse Landscape

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Classical hematology 1Breast 1

Conditions

Breast Neoplasms 76Neoplasm Metastasis 12Neoplasms 8Ovarian Neoplasms 6Endometrial Neoplasms 6Pancreatic Neoplasms 5Carcinoma, Renal Cell 5Sarcoma 4Neoplasms by Site 4Lymphoma, Non-Hodgkin 4Breast Diseases 4Squamous Cell Carcinoma of Head and Neck 3Multiple Myeloma 3Lymphoma 3Lung Neoplasms 3Liposarcoma 3Kidney Neoplasms 3Head and Neck Neoplasms 3Glioma 3Wilms Tumor 2Uterine Cervical Neoplasms 2Triple Negative Breast Neoplasms 2Sarcoma, Ewing 2Rhabdomyosarcoma 2Rhabdoid Tumor 2Recurrence 2Prostatic Neoplasms 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Osteosarcoma 2Neuroectodermal Tumors, Primitive, Peripheral 2

Interventions

apixaban 10Rivaroxaban 5Aspirin 4Enoxaparin 3abelacimab 2MAA868 2Heparin, Low-Molecular-Weight 2Dalteparin 2ribociclib 1palbociclib 1isoquercitrin 1enoxaparin sodium 1edoxaban 1abemaciclib 1Rosuvastatin Calcium 1N(4)-oleylcytosine arabinoside 1Educational Status 1Dabigatran 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Venous Thromboembolism × palbociclib × 1 year × Clear all
NCT07008508 2025-06-06

BRAVE-Cyclin

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Active not recruiting
300 enrolled
BreastClassical hematology

Breast Neoplasms, Cardiovascular Diseases, Venous Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡